Orthopedic clinic setup cost in India: ₹40 L – ₹5 Cr, and the fork that decides which end you land on

Orthopedic clinic setup cost in India runs from ₹40 L to ₹5 Cr, based on ICG's own engagement base across orthopedic clients. The cost to start an orthopedic clinic in India splits on one decision: build an operating theatre on site, or refer surgical cases out to a hospital you don't own. ₹40 L buys the conservative-care end of that split; ₹5 Cr buys the surgical end, implants and all.

Contents

• The ₹40 L – ₹5 Cr range, and the low end cardiac doesn't have
• Location and tier: the licensing floor doesn't move, but working capital does
• Cost drivers: implant inventory, and the licensing floor underneath it
• Revenue drivers: the surgical-fee and physiotherapy mix
• Break-even timeline: two different clocks
• Common mistakes first-time orthopedic investors make
• FAQ

The ₹40 L – ₹5 Cr range, and the low end cardiac doesn't have

Orthopedic clinic setup cost in India has a floor that most surgical specialties don't: a surgeon can run a genuinely profitable practice without ever owning an operating theatre. That's a real asymmetry against cardiology, where the ₹15 Cr floor already assumes a cath lab — an orthopedic practice's ₹40 L floor assumes the opposite, a clinic that never touches surgery at all and refers every operative case elsewhere.

The ₹40 L end covers OPD consultation, a C-arm or plain X-ray unit, a plaster room and physiotherapy space — a conservative-care practice built entirely around non-operative treatment and referral. The ₹5 Cr end covers a full day-care surgical centre: an owned OT, an arthroscopy tower, day-care beds and the implant inventory a surgical practice has to carry on its shelf before it ever bills a procedure. Both figures come from ICG's own engagement base across orthopedics clients, not a market survey.

The same add-versus-build logic drives a general clinic's capital plan, laid out at the cost-to-start-a-clinic breakdown — orthopedics is simply the specialty where that logic produces a genuine standalone option at the low end, not a smaller version of the surgical build. A surgeon weighing whether to operate at someone else's hospital instead of building their own OT will find that broader positioning question at ICG's hospitals industry page.

Location and tier: what a Tier 2 city actually saves you, and what it costs

Day-care surgical registration under state Clinical Establishments rules, and the biomedical waste authorisation that sits alongside it, are administered state by state — not city by city and not tier by tier. Orthopedic clinic investment in India therefore doesn't buy a lighter licensing floor by picking a Tier 2 city over a Tier 1 one; the floor is the same wherever the state has notified the Act. What tier actually changes is rent, staffing cost, and the referral-network time it takes for local physiotherapists, family physicians and sports-injury walk-ins to start sending cases to a clinic that didn't exist a year ago.

The trade runs deeper than rent, though, because orthopedics is unusually dependent on a referral ecosystem that a smaller city may not have built yet. Sports-injury volume concentrates where there are gyms, academies and corporate insurance; degenerative joint volume follows an ageing population and a physician network willing to refer for replacement rather than manage conservatively. A Tier 2 city can offer the second without much of the first, which shifts the case mix toward lower-ticket conservative work — the same clinic, in a cheaper building, earning against a different revenue line than the plan assumed.

Cost drivers: implant inventory, and the licensing floor underneath it

A knee or hip implant system isn't bought as a single SKU. A surgeon books a procedure without knowing the exact size that will fit until the joint is open, so the clinic has to hold a size range on the shelf — several femoral and tibial components, several head and cup sizes — and most of that range never gets used on any single patient. That's the working-capital problem this specialty carries that no other specialty : cash sitting in implant sets that may never convert into a billed procedure.

Consignment stock shifts that cash burden onto the implant distributor, who holds the range on the clinic's shelf and invoices only what's used in surgery, at the cost of a supplier relationship with its own minimum-volume expectations. Owned stock puts the full range on the clinic's own balance sheet, tying up capital before the first case is booked, in exchange for better per-unit pricing once volume is proven. Government price-capping on knee implants under NPPA's ceiling-price mechanism constrains margin specifically on owned stock, not on consignment fees — worth knowing before choosing one model over the other.

Arthroscopy setup cost in India sits inside this same equipment stack — an arthroscopy tower, alongside the implant inventory, is what separates a day-care surgical build from a conservative-care one. A C-arm or a plain X-ray unit both trigger AERB radiological safety clearance the same way they do for a cardiac cath lab; the shielding and staffing sequence is covered in ICG's cardiac hospital setup cost breakdown rather than repeated here. Underneath both sits the day-care surgical registration, filed under state Clinical Establishments rules, plus the biomedical waste authorisation any facility handling surgical waste needs. Neither carries a central fee: the Bio-Medical Waste Management Rules impose segregation and authorisation obligations without a published schedule, and the Clinical Establishments Act portal puts registration with the state rather than the centre. "Day-care registration: varies by state, confirm locally" is the honest budget line.

Revenue drivers: the surgical-fee and physiotherapy mix

One joint-replacement case booked for next week. Forty physiotherapy follow-up visits on the same month's schedule, every one of them attached to a case operated months ago. Orthopedic clinic revenue in India runs on exactly that mix — a one-off surgical fee that's high-ticket and lumpy, against a physiotherapy line that's low-ticket but repeats across weeks for the same patient. Physiotherapy is this specialty's annuity revenue, a line most other specialties simply don't have. Size the clinic on surgical case volume alone and that annuity sits underused; size it on physiotherapy footfall alone and the higher-margin surgical line does. The workable model is built on the mix.

The compounding is what owners miss. Take a single-OT centre and assume, purely to show the shape, that each joint procedure generates a course of physiotherapy visits running several weeks past discharge. By month three the physiotherapy caseload is no longer that month's surgical patients — it is the accumulated tail of every case operated since launch, still billing while new surgery is booked alongside it. Model the surgical line and the physiotherapy tail on separate schedules and the clinic's cash curve looks nothing like the single-line projection most first plans carry. ·

Break-even timeline: two different clocks

The two ends of this range do not share a break-even clock, and treating them as one model is where most orthopedic projections go wrong. A conservative-only practice reaches orthopedic clinic break-even on consultations and physiotherapy volume alone — faster, and on less capital, because it never carried an OT, an arthroscopy tower or implant inventory to begin with. A full surgical centre carries all three, so its clock runs on case volume per OT plus the physiotherapy tail those cases generate — slower to reach, and priced against the ₹5 Cr end of the range rather than the ₹40 L end.

A single-OT centre opening this year illustrates the surgical clock: OPD footfall is steady from month one, but case volume lags behind it, because referring physiotherapists and sports-medicine practices haven't yet sent enough cases to fill the OT calendar. Once referrals arrive, the physiotherapy tail each case generates adds volume the OT count never captures on its own, and the combined curve overtakes footfall as the number that actually matters.

Common mistakes first-time orthopedic investors make

More OT time is supposed to mean more revenue — that's the assumption most first-time orthopedic investors carry into their capital plan. What actually breaks the model first, more often than OT hours, is implant working capital.

A newly opened surgical centre in a Tier 2 city ordered a full owned-stock range across three implant systems before a single referral relationship had been tested, on the reasoning that a fuller shelf would convert to more bookings. Six months in, referral volume had validated only one of those three systems; the other two sat on the shelf as capital that wasn't earning anything, while the consignment terms the clinic had turned down at launch — dismissed then as a worse deal than owning stock outright — would have let a distributor carry that same range at a fraction of the tied-up cash. The centre also went ahead with its full arthroscopy build before its OPD-and-physiotherapy referral flow was proven, and treated its state day-care registration as a formality because the central portal listed no fee, only to find the actual state-level timeline ran longer than the equipment lead time it had planned around. By the time referral volume caught up, the physiotherapy staffing needed to capture the annuity revenue in the mix hadn't been budgeted either — the therapists were hired after the surgical backlog had already built a waitlist.

FAQ

What's the minimum viable setup if I don't want to build my own OT? A conservative-care practice built around OPD consultation, a C-arm or plain X-ray, a plaster room and physiotherapy space is a genuinely profitable standalone option — no OT, no implant inventory, no arthroscopy tower required. This sits at the ₹40 L end of the range, with every surgical case referred out to a hospital rather than operated on site.

How much working capital does implant inventory actually tie up before the first procedure? It depends on whether the stock is owned or held on consignment, and how many implant systems and size ranges the clinic carries at launch. Owned stock ties up capital across a full size range before a single case is billed; consignment shifts most of that burden to the distributor in exchange for less favourable per-unit pricing.

What's the real difference in cost between consignment and owned implant stock? Consignment means the distributor holds the size range on the clinic's shelf and invoices only what's used in surgery, at the cost of a supplier relationship with its own minimum-volume expectations. Owned stock means the clinic carries that same range on its own balance sheet, tying up more capital up front in exchange for better per-unit pricing once volume is proven.

Does a plain X-ray unit trigger AERB registration, or only a C-arm? Both trigger AERB radiological safety clearance — a plain X-ray unit and a C-arm are treated the same way under AERB's guidance. The physical shielding and radiological safety officer requirements involved are covered in detail on ICG's cardiac hospital setup cost breakdown, which walks through the same clearance sequence.

What's the actual cost of day-care surgical registration, state by state? There's no single number, because the fee is set at the state level rather than published on the central Clinical Establishments portal. The honest budgeting line is to confirm the fee and timeline directly with the relevant state health department rather than assume a national figure.

How does physiotherapy revenue change my break-even model versus a pure-surgical practice? A pure-surgical practice's break-even tracks case volume per OT alone, which is slower and needs more capital to reach. Adding physiotherapy's repeat-visit revenue against that same case volume shortens the runway, because each surgical case generates weeks of follow-up billing a pure-surgical model doesn't count.

How many surgical cases per month does a single-OT orthopedic centre need to break even? There is no single number, because the answer moves with the centre's cost base, its payer mix and how much physiotherapy attaches to each surgical case. Model those three first; a case-count target derived without them will be wrong in either direction.

What's the biggest capital mistake first-time orthopedic investors make? Sizing implant stock, and committing to a full arthroscopy build, before referral volume has actually validated the practice — more often than underestimating OT hours themselves. The cash gets locked into unused implant sets before case volume exists to justify the size range carried.

ICG's marketing engagement typically accounts for engagement-specific and clinic-model-dependent; see CPQL benchmarks for methodology of this clinic type's opex, benchmarked to an orthopedic CPQL of ₹590 (ICG) against a market average of ₹1,300 — see ICG's CPQL benchmarks. That figure is drawn from 46 active healthcare client engagements, a rolling 12-month window from July 2025 to July 2026, across Delhi NCR, Mumbai, Bangalore, Chennai, Hyderabad and Kolkata, last verified 26 July 2026. Patient lifetime value in orthopedics runs ₹1.5 L to ₹5 L per procedure, on the same approved row.

For clinics and surgical centres evaluating a marketing partner ahead of launch, the specialty-specific breakdown sits at ICG's orthopedics marketing agency page. Any pre-launch campaign is also bound by the NMC Ethics Code 2026, which sets the boundary on outcome claims and comparative superiority for a new surgical practice — covered in ICG's NMC Section 6 compliance guide.

Written by Rohit Gupta, Co-Founder, Business & Growth Reviewed by Abhash Kumar, Co-Founder, Strategy

Neither the author nor the reviewer is a clinician; this is a capital-planning and marketing-economics analysis, not clinical or medico-legal advice.